Sequana Medical Announces 2019 Full Year Results and 2020 Outlook

NEXT STORY
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma® the only gene therapy for patients with spinal muscular atrophy (SMA)
PREV STORY
The North America genetic testing services market is expected to reach US$ 7,406.0 Mn in 2027 from US$ 3,044.4 Mn in 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

author_avatar
NASDAQ Market News

Global Environmental Testing Market Report 2021: Market is Expected to Reach $12.5 Billion by the year 2027 – Inadequate Infrastructure Remains Key Challenge

author_avatar
NASDAQ Market News

AB Science: New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating COVID-19

author_avatar
NASDAQ Market News